FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035586057> ?p ?o ?g. }

• W3035586057 abstract "Abstract House-dust mites (HDM) allergy is the prevailing condition in subjects allergic to inhalants. Clinical studies with HDM extracts—either subcutaneous (SCIT) or sublingual (SLIT) have long been characterized by small sample size, varying allergen doses, and poorly defined endpoints assessing disease severity. In the last decade, well-designed, randomized, controlled studies recruiting thousands of patients have been conducted with newly developed HDM sublingual tablets (SQ ® -HDM tablets). This drug is easily dispersible in the oral cavity due to the patented Zydis ® technology and its allergen composition is balanced in terms of group I and group II major mite allergen content, reflecting the equal contribution of the two components to HDM sensitization. HDM is the most common allergen associated with asthma. Clinical efficacy of the SQ ® HDM SLIT-tablet in HDM allergic asthma has been evaluated in randomized, double-blind, placebo-controlled trials. Both endpoints related to “present” asthma control (inhaled corticosteroid—ICS) as well as endpoints related to “future” asthma control (occurrence of asthma exacerbations) were included in these studies, in agreement with GINA (Global Initiative for Asthma) guidelines. Based on the positive results of these studies, SQ ® -HDM SLIT-tablets were approved Europe-wide as registered drug for treating moderate-to-severe allergic rhinitis with or without allergic asthma and not well controlled HDM allergic asthma, associated with allergic rhinitis of any severity. GINA guidelines in 2017 included SLIT-tablet-based immunotherapy as an “add-on” treatment for asthmatic patients sensitized to HDM; indeed, allergen immunotherapy (AIT) is considered to be a complementary treatment option that targets the immunological of allergic diseases, representing the only treatment potentially disease-modifier or, at least, with a long-term efficacy. The availability of a safe, standardized, registered treatment for HDM respiratory allergies is pivotal in the immunotherapy field, pushing it out of a century-long limbo of amatorial interest towards the full dignity deserved by the only casual treatment of respiratory allergies." @default.
• W3035586057 created "2020-06-19" @default.
• W3035586057 creator A5030436210 @default.
• W3035586057 creator A5075850586 @default.
• W3035586057 creator A5082606231 @default.
• W3035586057 date "2020-06-11" @default.
• W3035586057 modified "2023-10-14" @default.
• W3035586057 title "New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets" @default.
• W3035586057 cites W1132113666 @default.
• W3035586057 cites W1548476693 @default.
• W3035586057 cites W1590921662 @default.
• W3035586057 cites W1608960808 @default.
• W3035586057 cites W1900907547 @default.
• W3035586057 cites W1969976800 @default.
• W3035586057 cites W1979025848 @default.
• W3035586057 cites W1994145602 @default.
• W3035586057 cites W1997729446 @default.
• W3035586057 cites W2002375125 @default.
• W3035586057 cites W2005586401 @default.
• W3035586057 cites W2010928181 @default.
• W3035586057 cites W2011828164 @default.
• W3035586057 cites W2028280773 @default.
• W3035586057 cites W2055139501 @default.
• W3035586057 cites W2088425922 @default.
• W3035586057 cites W2116583914 @default.
• W3035586057 cites W2116636957 @default.
• W3035586057 cites W2121327269 @default.
• W3035586057 cites W2142589482 @default.
• W3035586057 cites W2150187523 @default.
• W3035586057 cites W2150203626 @default.
• W3035586057 cites W2164132449 @default.
• W3035586057 cites W2166467474 @default.
• W3035586057 cites W2175077154 @default.
• W3035586057 cites W2271602246 @default.
• W3035586057 cites W2284730656 @default.
• W3035586057 cites W2302277303 @default.
• W3035586057 cites W2344044328 @default.
• W3035586057 cites W2400133528 @default.
• W3035586057 cites W2511719925 @default.
• W3035586057 cites W2554771773 @default.
• W3035586057 cites W2597175831 @default.
• W3035586057 cites W2763673288 @default.
• W3035586057 cites W2765370282 @default.
• W3035586057 cites W2808597111 @default.
• W3035586057 cites W2883383575 @default.
• W3035586057 cites W2905535936 @default.
• W3035586057 doi "https://doi.org/10.1186/s12948-020-00124-7" @default.
• W3035586057 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7288442" @default.
• W3035586057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32536827" @default.
• W3035586057 hasPublicationYear "2020" @default.
• W3035586057 type Work @default.
• W3035586057 sameAs 3035586057 @default.
• W3035586057 citedByCount "2" @default.
• W3035586057 countsByYear W30355860572021 @default.
• W3035586057 crossrefType "journal-article" @default.
• W3035586057 hasAuthorship W3035586057A5030436210 @default.
• W3035586057 hasAuthorship W3035586057A5075850586 @default.
• W3035586057 hasAuthorship W3035586057A5082606231 @default.
• W3035586057 hasBestOaLocation W30355860571 @default.
• W3035586057 hasConcept C126322002 @default.
• W3035586057 hasConcept C168563851 @default.
• W3035586057 hasConcept C199215989 @default.
• W3035586057 hasConcept C203014093 @default.
• W3035586057 hasConcept C207480886 @default.
• W3035586057 hasConcept C2776042228 @default.
• W3035586057 hasConcept C2777037608 @default.
• W3035586057 hasConcept C2778166374 @default.
• W3035586057 hasConcept C2779350572 @default.
• W3035586057 hasConcept C2779787640 @default.
• W3035586057 hasConcept C2780510475 @default.
• W3035586057 hasConcept C54355233 @default.
• W3035586057 hasConcept C71924100 @default.
• W3035586057 hasConcept C86803240 @default.
• W3035586057 hasConceptScore W3035586057C126322002 @default.
• W3035586057 hasConceptScore W3035586057C168563851 @default.
• W3035586057 hasConceptScore W3035586057C199215989 @default.
• W3035586057 hasConceptScore W3035586057C203014093 @default.
• W3035586057 hasConceptScore W3035586057C207480886 @default.
• W3035586057 hasConceptScore W3035586057C2776042228 @default.
• W3035586057 hasConceptScore W3035586057C2777037608 @default.
• W3035586057 hasConceptScore W3035586057C2778166374 @default.
• W3035586057 hasConceptScore W3035586057C2779350572 @default.
• W3035586057 hasConceptScore W3035586057C2779787640 @default.
• W3035586057 hasConceptScore W3035586057C2780510475 @default.
• W3035586057 hasConceptScore W3035586057C54355233 @default.
• W3035586057 hasConceptScore W3035586057C71924100 @default.
• W3035586057 hasConceptScore W3035586057C86803240 @default.
• W3035586057 hasIssue "1" @default.
• W3035586057 hasLocation W30355860571 @default.
• W3035586057 hasLocation W30355860572 @default.
• W3035586057 hasLocation W30355860573 @default.
• W3035586057 hasLocation W30355860574 @default.
• W3035586057 hasOpenAccess W3035586057 @default.
• W3035586057 hasPrimaryLocation W30355860571 @default.
• W3035586057 hasRelatedWork W1981593464 @default.
• W3035586057 hasRelatedWork W2035048904 @default.
• W3035586057 hasRelatedWork W2111715937 @default.
• W3035586057 hasRelatedWork W2336733642 @default.
• W3035586057 hasRelatedWork W2356776597 @default.
• W3035586057 hasRelatedWork W2522206450 @default.

• next